Dr. Steven Brodie is the Director of Molecular Genetics and Cytogenetics at NeoGenomics Laboratories, Fort Myers, FL.
Prior to joining NeoGenomics in 2011, Dr. Brodie served as Senior Director of Cytogenetics, Assistant Director of Molecular Genetics, and Scientific Director of Maternal Serum Screening at Specialty Laboratories/Quest Diagnostics in Valencia Ca. Dr. Brodie trained Pathology residents in genetic testing at both Loma Linda University Medical Center where he served as the Affiliate Rotation Director and University of Southern California, Keck School of Medicine where he served as a Clinical Assistant Professor of Pathology. Prior to joining Quest Diagnostics, he held a variety of research and clinical positions at the National Institutes of Health, University of New Mexico school of Medicine, and UCLA David Geffen School of Medicine. Dr. Brodie received his genetics training at the UCLA/Cedar-Sinai Medical Center medical genetics training program in Los Angeles Ca.
He received his Ph.D. from UNM School of Medicine and completed Clinical Genetics training in Cytogenetics and Molecular Genetics at UCLA. Dr. Brodie is Board Certified by the American Board of Medical Genetics in these specialties and holds Directors Licenses in the States of Florida, California, and New York.
Throughout his career, Dr. Brodie has held various research and clinical positions at the NIH, UNM and UCLA, and comes to us after directing high through put testing in Cytogenetics, FISH, Molecular Genetics and Oncology for Quest Diagnostics, Nichols Institute. He is also a CAP approved inspector.
Retrieved from neogenomics.com.
